Hikma Pharmaceu
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
0143-9525-10 |
ANDA |
HIKMA |
2020-01-30 |
|
WG Critical Car
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
44567-601-04 |
NDA |
HQ SPCLT PHARMA |
2018-06-22 |
|
TAGI Pharma, In
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
51224-215-10 |
ANDA |
TAGI |
2020-11-23 |
|
AuroMedics Phar
|
intravenous |
dexmedetomidine hydrochloride in 0.9% sodium chloride |
4 ug/mL |
55150-297-10 |
ANDA |
EUGIA PHARMA |
2016-03-17 |
|
Sun Pharmaceuti
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
57664-596-50 |
ANDA |
GLAND |
2015-08-20 |
|
Gland Pharma Li
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
68083-239-10 |
ANDA |
GLAND PHARMA LTD |
2020-06-03 |
|
Precision Dose,
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
68094-147-20 |
ANDA |
TAGI |
2020-11-23 |
|
Hospira, Inc.
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
0409-1174-10 |
NDA |
HOSPIRA |
2022-03-07 |
|
Par Pharmaceuti
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
42023-187-10 |
ANDA |
PAR STERILE PRODUCTS |
2014-08-18 |
|
General Injecta
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
52584-638-02 |
NDA |
HOSPIRA |
2013-03-13 |
|
Baxter Healthca
|
intravenous |
dexmedetomidine hydrochloride |
400 ug/100mL |
0338-9557-12 |
ANDA |
BAXTER HLTHCARE CORP |
2018-08-21 |
|
Piramal Critica
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
66794-234-44 |
ANDA |
GLAND PHARMA LTD |
2020-06-03 |
|
Amneal Pharmace
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
70121-1389-7 |
ANDA |
AMNEAL PHARMS CO |
2020-05-20 |
|
Hospira, Inc.
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
0409-1638-02 |
NDA |
HOSPIRA |
2013-03-13 |
|
CIVICA, INC.
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
72572-127-10 |
ANDA |
SLAYBACK PHARMA LLC |
2019-12-04 |
|
BioXcel Therape
|
sublingual |
dexmedetomidine |
180 ug/1 |
81092-1180-1, 81092-1180-3 |
NDA |
BIOXCEL |
2022-07-01 |
|
Akorn
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
17478-055-02 |
ANDA |
AKORN |
2014-11-24 |
|
Dr.Reddy's Labo
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
43598-976-58 |
ANDA |
GLAND PHARMA LTD |
2020-06-03 |
|
WG Critical Car
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
44567-602-24 |
NDA |
HQ SPCLT PHARMA |
2018-06-22 |
|
WG Critical Car
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
44567-603-24 |
NDA |
HQ SPCLT PHARMA |
2018-06-22 |
|
Baxter Healthca
|
intravenous |
dexmedetomidine hydrochloride |
200 ug/50mL |
0338-9555-24 |
ANDA |
BAXTER HLTHCARE CORP |
2018-08-21 |
|
Precision Dose,
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
68094-047-10 |
ANDA |
TAGI |
2020-11-23 |
|
CIVICA, INC.
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
72572-128-08 |
ANDA |
SLAYBACK PHARMA LLC |
2019-12-04 |
|
Baxter Healthca
━ NovaPlus
|
intravenous |
dexmedetomidine hydrochloride in 0.9% sodium chloride |
400 ug/100mL |
43066-557-12 |
ANDA |
BAXTER HLTHCARE CORP |
2018-08-21 |
|
Dr.Reddy's Labo
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
43598-975-58 |
ANDA |
GLAND PHARMA LTD |
2020-06-03 |
|
Piramal Critica
|
intravenous |
dexmedetomidine |
200 ug/2mL |
66794-230-42 |
ANDA |
GLAND |
2015-08-20 |
|
Piramal Critica
━ NovaPlus
|
intravenous |
dexmedetomidine |
200 ug/2mL |
66794-233-42 |
ANDA |
GLAND |
2015-08-20 |
|
Mylan Instituti
|
intravenous |
dexmedetomidine |
100 ug/mL |
67457-251-02 |
ANDA |
MYLAN INSTITUTIONAL |
2014-08-18 |
|
Medical Purchas
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
71872-7030-1 |
ANDA |
ACCORD HLTHCARE |
2016-02-09 |
|
Medical Purchas
|
intravenous |
dexmedetomidine hcl |
100 ug/mL |
71872-7218-1 |
ANDA |
HIKMA |
2017-04-26 |
|
Accord Healthca
━ NovaPlus
|
intravenous |
dexmedetomidine |
100 ug/mL |
16729-432-93 |
ANDA |
ACCORD HLTHCARE |
2016-02-09 |
|
Fresenius Kabi
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
63323-421-02 |
ANDA |
FRESENIUS KABI USA |
2015-09-18 |
|
Henry Schein, I
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
0404-9938-02 |
NDA |
HOSPIRA |
2013-03-13 |
|
Slayback Pharma
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
71225-126-04, 71225-126-05, 71225-126-06 |
ANDA |
SLAYBACK PHARMA LLC |
2019-12-04 |
|
BioXcel Therape
|
sublingual |
dexmedetomidine |
120 ug/1 |
81092-1120-1, 81092-1120-3 |
NDA |
BIOXCEL |
2022-07-01 |
|
TAGI Pharma, In
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
51224-115-20 |
ANDA |
TAGI |
2020-11-23 |
|
AuroMedics Phar
|
intravenous |
dexmedetomidine hydrochloride in 0.9% sodium chloride |
4 ug/mL |
55150-296-10 |
ANDA |
EUGIA PHARMA |
2016-03-17 |
|
Mylan Instituti
|
intravenous |
dexmedetomidine hydrochloride |
200 ug/50mL |
67457-924-50 |
ANDA |
MYLAN LABS LTD |
2020-08-27 |
|
Gland Pharma Li
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
68083-238-20 |
ANDA |
GLAND PHARMA LTD |
2020-06-03 |
|
Hospira, Inc.
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
0409-1434-01 |
NDA |
HOSPIRA |
2013-03-13 |
|
Sandoz Inc.
|
intravenous |
dexmedetomidine hydrochloride in 0.9% sodium chloride |
4 ug/mL |
0781-3495-95 |
ANDA |
JIANGSU PHARMS |
2020-06-12 |
|
Accord Healthca
|
intravenous |
dexmedetomidine |
100 ug/mL |
16729-239-93 |
ANDA |
ACCORD HLTHCARE |
2016-02-09 |
|
Baxter Healthca
━ NovaPlus
|
intravenous |
dexmedetomidine hydrochloride in 0.9% sodium chloride |
200 ug/50mL |
43066-555-24 |
ANDA |
BAXTER HLTHCARE CORP |
2018-08-21 |
|
Precision Dose,
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
68094-247-10 |
ANDA |
TAGI |
2020-11-23 |
|
Zydus Pharmaceu
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
68382-124-25 |
ANDA |
ZYDUS PHARMS |
2018-02-27 |
|
Athenex Pharmac
|
intravenous |
dexmedetomidine |
100 ug/mL |
70860-605-02, 70860-605-03 |
ANDA |
JIANGSU PHARMS |
2020-06-12 |
|
Slayback Pharma
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
71225-132-02 |
ANDA |
SLAYBACK PHARMA LLC |
2019-12-04 |
|
Hospira, Inc.
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
0409-3301-10 |
NDA |
HOSPIRA |
2022-03-07 |
|
Medical Purchas
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
71872-7031-1 |
ANDA |
EUGIA PHARMA |
2016-03-17 |
|
Medical Purchas
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
71872-7122-1 |
ANDA |
GLAND |
2015-08-20 |
|
Medical Purchas
|
intravenous |
dexmedetomidine |
100 ug/mL |
71872-7150-1 |
ANDA |
JIANGSU PHARMS |
2020-06-12 |
|
Sandoz Inc.
|
intravenous |
dexmedetomidine hydrochloride in 0.9% sodium chloride |
4 ug/mL |
0781-3493-95 |
ANDA |
JIANGSU PHARMS |
2020-06-12 |
|
Sandoz Inc.
|
intravenous |
dexmedetomidine hydrochloride in 0.9% sodium chloride |
4 ug/mL |
0781-3494-95 |
ANDA |
JIANGSU PHARMS |
2020-06-12 |
|
Hikma Pharmaceu
|
intravenous |
dexmedetomidine hcl |
100 ug/mL |
0143-9532-25 |
ANDA |
HIKMA |
2017-04-26 |
|
WG Critical Car
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
44567-600-04 |
NDA |
HQ SPCLT PHARMA |
2018-06-22 |
|
AuroMedics Phar
|
intravenous |
dexmedetomidine |
100 ug/mL |
55150-209-02 |
ANDA |
EUGIA PHARMA |
2016-03-17 |
|
Piramal Critica
|
intravenous |
dexmedetomidine |
100 ug/mL |
66794-238-41, 66794-238-43 |
ANDA |
PIRAMAL CRITICAL |
2021-09-03 |
|
Mylan Instituti
|
intravenous |
dexmedetomidine hydrochloride |
400 ug/100mL |
67457-925-10 |
ANDA |
MYLAN LABS LTD |
2020-08-27 |
|
Meitheal Pharma
|
intravenous |
dexmedetomidine |
100 ug/mL |
71288-505-03 |
ANDA |
MEITHEAL |
2019-01-18 |
|
Hospira, Inc.
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
0409-1660-10, 0409-1660-20, 0409-1660-50 |
NDA |
HOSPIRA |
2013-03-13 |
|
Piramal Critica
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
66794-235-41 |
ANDA |
GLAND PHARMA LTD |
2020-06-03 |
|
Amneal Pharmace
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
70121-1388-8 |
ANDA |
AMNEAL PHARMS CO |
2020-05-20 |
|
Cadila Healthca
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
70771-1319-7 |
ANDA |
ZYDUS PHARMS |
2018-02-27 |
|
Slayback Pharma
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
71225-133-02 |
ANDA |
SLAYBACK PHARMA LLC |
2019-12-04 |
|
Par Pharmaceuti
|
intravenous |
dexmedetomidine hydrochloride |
100 ug/mL |
42023-146-25 |
ANDA |
PAR STERILE PRODUCTS |
2014-08-18 |
|
Par Pharmaceuti
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
42023-186-20 |
ANDA |
PAR STERILE PRODUCTS |
2014-08-18 |
|
Hikma Pharmaceu
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
0143-9526-10 |
ANDA |
HIKMA |
2020-01-30 |
|
TAGI Pharma, In
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
51224-015-10 |
ANDA |
TAGI |
2020-11-23 |
|
Fresenius Kabi
|
intravenous |
dexmedetomidine hydrochloride |
4 ug/mL |
63323-671-00, 63323-671-20, 63323-671-50 |
ANDA |
FRESENIUS KABI USA |
2018-11-29 |
|
ACTAVIS INC
|
injection |
dexmedetomidine hydrochloride |
EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) |
|
ANDA |
|
2016-10-17 |
|
SANDOZ INC
|
injection |
dexmedetomidine hydrochloride |
EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) |
|
ANDA |
|
2016-06-14 |
|
TEVA PHARMACEUT
|
injection |
dexmedetomidine hydrochloride |
EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) |
|
ANDA |
|
2017-11-28 |
|